48,830
edits
Difference between revisions of "Epithelioid hemangioendothelioma"
Jump to navigation
Jump to search
Epithelioid hemangioendothelioma (view source)
Revision as of 00:38, 3 April 2014
, 00:38, 3 April 2014no edit summary
| Line 28: | Line 28: | ||
| Other = | | Other = | ||
| ClinDDx = | | ClinDDx = | ||
| Tx = | | Tx = resection | ||
}} | }} | ||
'''Epithelioid hemangioendothelioma''', abbreviated '''EHE''', is rare malignant [[vascular tumours|vascular tumour]]. | '''Epithelioid hemangioendothelioma''', abbreviated '''EHE''', is rare malignant [[vascular tumours|vascular tumour]]. | ||
| Line 38: | Line 38: | ||
*Adults - wide age range. | *Adults - wide age range. | ||
*Associated with oral contraceptives, vinyl chloride.<ref name=pmid20165548/> | *Associated with oral contraceptives, vinyl chloride.<ref name=pmid20165548/> | ||
*Rare - | *Rare.<ref name=pmid23589078/> | ||
Treatment: | |||
*Excision<ref name=pmid8941001/> if feasible. | |||
*Chemotherapy - not standardized.<ref name=pmid23589078>{{Cite journal | last1 = Chevreau | first1 = C. | last2 = Le Cesne | first2 = A. | last3 = Ray-Coquard | first3 = I. | last4 = Italiano | first4 = A. | last5 = Cioffi | first5 = A. | last6 = Isambert | first6 = N. | last7 = Robin | first7 = YM. | last8 = Fournier | first8 = C. | last9 = Clisant | first9 = S. | title = Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO). | journal = Cancer | volume = 119 | issue = 14 | pages = 2639-44 | month = Jul | year = 2013 | doi = 10.1002/cncr.28109 | PMID = 23589078 }}</ref> | |||
Prognosis - liver: | Prognosis - liver: | ||